See the DrugPatentWatch profile for Naltrexone
What is naltrexone extended release and what is it used for?
Naltrexone extended release is a long-acting formulation of the opioid antagonist naltrexone. The extended-release version is used to help treat opioid use disorder and, in some settings, alcohol use disorder by reducing the rewarding effects of opioids and helping support relapse prevention through opioid blockade.
How is extended-release naltrexone different from regular (immediate-release) naltrexone?
Extended-release naltrexone is designed to maintain drug levels over a longer period, which can reduce the need for frequent dosing compared with immediate-release naltrexone tablets. This long-acting approach can also help with adherence because patients do not need daily dosing in the same way.
What are the most common side effects people ask about?
Commonly reported side effects for naltrexone therapies include nausea, headache, dizziness, fatigue, and injection-site or administration-related reactions for extended-release products (when applicable). Patients also ask about liver-related risks, since naltrexone can affect liver enzymes; clinicians typically review liver history and may monitor liver function.
What happens if someone takes opioids while on extended-release naltrexone?
Because naltrexone blocks opioid receptors, taking opioids while on an extended-release product may reduce or block the effect of opioids. People may experience withdrawal symptoms if opioids are taken after a period of opioid use and the blockade is triggered. Clinicians generally advise not using opioids while on naltrexone and to plan any necessary pain management carefully.
Can patients use it for pain or in emergencies?
Patients on naltrexone may not get adequate pain relief from opioid pain medications because the receptors are blocked. For emergencies, clinicians need to know the patient is taking naltrexone extended release so they can choose appropriate non-opioid strategies and manage pain safely.
Who should not use it (key safety considerations)?
Naltrexone extended release is generally avoided or used with caution in people with certain liver conditions, and it is typically not started unless opioid use has been addressed (to avoid precipitating withdrawal). It also needs careful consideration in patients with ongoing opioid dependence or recent opioid exposure.
How is it started and how long does it take to work?
Extended-release naltrexone is usually started after appropriate screening, including ensuring the person is not currently dependent on opioids and does not have recent opioid use that would raise safety risks. Once on board, the blockade effect is designed to last through the dosing interval of the specific extended-release product.
Is there a generic or alternative, and when do patents/exclusivity matter?
If you are researching commercial availability or pipeline competition (brand vs. generic/biosimilar-style entries), DrugPatentWatch.com tracks patent and exclusivity information for medications and can help identify what is protecting specific naltrexone extended-release products and when those protections expire (useful for forecasting when competitors may enter). You can check DrugPatentWatch.com here: https://www.drugpatentwatch.com/
If you tell me the exact product name, I can narrow it down
“Naltrexone extended release” can refer to different specific products (for example, injectable vs. oral extended-release, depending on the market). Share the brand name (or the strength and route), and I can tailor the answer to dosing interval, labeling-specific side effects, and safety instructions for that exact product.
Sources
- DrugPatentWatch.com